Business Wire

OH-UWL

26.4.2022 19:42:09 CEST | Business Wire | Press release

Share
UWL Launches Express Service from Vietnam to Seattle

UWL, a top 10 American-owned NVOCC and leading provider of global 3PL services, has contracted with Swire Shipping, a multi-purpose liner service, to launch a new, exclusive express service, departing from Ho Chi Minh City and arriving at the Port of Seattle in 18 days. Providing speed and predictability, the bi-weekly service offers the fastest trip from Vietnam to the US. This revolutionary agreement is the first dedicated ocean service by an NVOCC in the trade.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220426006070/en/

“Customers have been asking for creative solutions during this extremely challenging market, and this first-of-its-kind service is part of our response. Congestion and rate spikes will come and go, but the root issues remain. US importers are pushing for more creativity and controlled reliable solutions to manage supply chain risk,” UWL President Duncan Wright said.

The service offers priority berthing at both origin and destination, and a dedicated equipment pool for suppliers in Ho Chi Minh City. This includes 6,000 brand-new ocean containers, with 40-foot-high cube and 20-foot containers already in the rotation. Predictability is assured, as schedules are published six months in advance, with two sailings per month.

Upon arrival in Seattle, those needing warehousing or distribution space can take advantage of UWL’s sister company, World Distribution Services (WDS), and its brand-new 300,000 sq. ft. facility near Tacoma, WA, just a short drive away from the Port of Seattle.

“In joining forces with UWL, an innovative and integrated logistics provider to American BCOs, we are confident that our ocean express solution will be compelling to importers and exporters who need a direct port-to-port, fast, and reliable service between Vietnam and the Pacific Northwest,” said Rufus Frere-Smith, Regional Head, Americas, Swire Shipping, which facilitates trade in more than 90 countries and across 400 ports. “Our partnership is built on a joint vision of responding to customers’ desire for reliable, safe, and innovative shipping solutions.”

Mr. Wright noted: “We have seen incredibly strong demand for this service already, which tells us that fast and reliable niche services are here to stay. Our relationship with Swire Shipping is critical to making all this work. Their remarkable 150-year history and robust knowledge of ocean shipping and strong Asia legacy, combined with UWL’s culture of innovation, brings this dedicated service to life.”

Mr. Frere-Smith commented: “We have deployed new state-of-the-art, fuel-efficient vessels that will sail at high speed, safely and sustainably. We are confident customers and BCOs will find this direct, express service to be extremely effective in shipping their high value products and getting to market quickly.”

About UWL

UWL is a top 10 American-owned NVOCC and leading provider of global 3PL services. They take pride in delivering seamless supply chain solutions backed by a team of creative problem-solvers. Specializing in ocean transportation, air freight, road and rail, warehousing and distribution, project cargo, and customs house brokerage, their proof is in owned assets: a national network of distribution centers, dependable trucking capacity, and WorldScope , a user-friendly data management platform that delivers transparency and visibility customers can count on. Wherever your freight needs to go, they can help get it there. To find out more, visit their website at www.shipuwl.com

About Swire Shipping

Swire Shipping is a privately owned organization that was founded in 1872 and now comprises over 600 employees in 20 countries and owns and deploys over 30 vessels in the intra-Asia, Australasia, and Polynesia trades. It is part of the Swire Group which is a Hong Kong- and London-based British conglomerate. Many of its core businesses can be found within the Asia Pacific region, where traditionally Swire’s operations have centered on Hong Kong and mainland China. Its subsidiaries include Cathay Pacific Airlines, Swire Properties, China Navigation Company, Swire Hotels and Swire Resources.

About World Group

World Group was founded over 60 years ago as a pioneer in vessel agency services on the Great Lakes. Today, they are home to a portfolio of globally trusted brands that deliver customers end-to-end supply chain and logistics solutions, including ContainerPort Group, UWL, World Distribution Services, and World Shipping, Inc. With industry-leading products in ocean drayage and domestic trucking, freight forwarding and air freight, customs house brokerage, vessel husbandry, and warehousing and distribution, customers around the globe use their services to simplify supply chains and reliably move freight.

Offering career opportunities across the country for innovators in the transportation industry, their award-winning culture is anchored in people who live and breathe the company’s core values daily. Learn how to join the World Group family by visiting their careers page.

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Backed by Investments Exceeding $1 Billion, PCI Pharma Services Announces Major Expansion of US Sterile Fill-Finish and Drug-Device Delivery Combination Capabilities27.4.2026 16:00:00 CEST | Press release

As pharma manufacturers prioritize US supply chain resilience, highlights include high-speed isolator filling lines for prefilled syringes, cartridges and vials, and drug-device combination assembly and packaging. PCI Pharma Services (“PCI”) – a world-leading integrated global contract development and manufacturing organization (CDMO) focused on innovative biologic and small molecule therapies – announced a series of major infrastructure investments that substantially deepen its sterile fill-finish and advanced drug delivery capabilities. As pharma manufacturers and their development partners increasingly prioritize US supply chain resilience, PCI’s latest investments come as part of a broader commitment exceeding $1 billion across the CDMO’s US and European operations, reinforcing its ability to provide seamless support for drug product development and manufacturing, clinical trial supply and drug-device combination assembly from clinical stages through commercial launch – all underpi

Pure Lithium Appoints Renowned Battery Expert Dr. Yuan Gao to Board of Directors27.4.2026 15:53:00 CEST | Press release

Pure Lithium Corporation, a vertically integrated lithium metal battery technology company, is pleased to announce that world-renowned inventor and battery expert Dr. Yuan Gao has joined the company’s Board of Directors. Dr. Gao has been an invaluable member of Pure Lithium’s Scientific Advisory Board since October of 2023. "We are thrilled to have Dr. Gao join our board as we focus on rapidly scaling our technology in the most capital efficient manner possible,” said Pure Lithium Founder, Chairman and CEO Emilie Bodoin. “Dr. Gao is a brilliant scientist who also has deep commercial expertise, a rare combination. He is also unique in the industry because his experience spans the entire battery materials value chain, including all of Pure Lithium’s verticals. His insights over the years have been critical in advancing our technology, and his experience as a director of public companies will strengthen our board.” Dr. Gao commented: “I am thrilled to join the board of Pure Lithium Corpor

Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development27.4.2026 15:00:00 CEST | Press release

Phase 1 dose-escalation trial represents the first clinical trial of a product developed using the AraLinQ™ ADC technology and marks Taiho’s expansion into the clinical development of ADCs for oncology Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG (“Araris”) today announced that the U.S. Food and Drug Administration (FDA) has completed its Investigational New Drug (IND) review period for ARC-02, an antibody-drug conjugate (ADC) being developed for the treatment of non-Hodgkin lymphoma, enabling Taiho Oncology to initiate a Phase 1 dose-escalation clinical trial of ARC-02. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427127507/en/ Taiho Pharmaceutical acquired Araris Biotech in March 2025, expanding Taiho group’s capabilities in biologics and ADC research and development. Araris is a spin-off of the Paul Scherrer Institute and ETH in Switzerland focused on the development of antibody-drug co

Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 202627.4.2026 15:00:00 CEST | Press release

Premier global event to highlight how organizations are bringing data to life to power everything from AI to BI Boomi, the data activation company, today announced Boomi World 2026, its premier annual user conference, taking place May 11 - 14, 2026 in Chicago, IL. The event will bring together customers, partners, and industry leaders from around the world to explore how data activation is transforming the enterprise and accelerating the path to AI-driven outcomes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427600340/en/ Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 2026 Boomi World 2026 will spotlight data activation — bringing data to life to power AI, analytics, and intelligent automation. Attendees will gain firsthand insights into how the Boomi Enterprise Platform enables businesses to unify data, streamline operations, and innovate faster in an increasingly agentic world.

Axinn Appoints Rachael Philbin as Chief Innovation Officer27.4.2026 15:00:00 CEST | Press release

Appointment Reflects Firm's Vision for the Future of Legal Practice Axinn, Veltrop & Harkrider LLP today announced the appointment of Rachael Philbin as Chief Innovation Officer, reinforcing the firm’s continued investment in advanced solutions and technology for legal services delivery. Philbin joins from Proskauer Rose LLP, where she served as Innovation & Transformation Officer. Based in Axinn's New York office, she will lead the firm’s AI and legal technology initiatives as well as knowledge management efforts, accelerating adoption and integration across its antitrust, intellectual property, and litigation practices. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427277725/en/ Rachael Philbin joins Axinn, Veltrop & Harkrider LLP as Chief Innovation Officer. “As Axinn continues to grow, we are making deliberate investments in the capabilities that enable our lawyers to deliver service and results at the highest level

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye